Susquehanna International Group’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$566K Buy
248,300
+233,500
+1,578% +$538K ﹤0.01% 9347
2025
Q4
$41.4K Sell
14,800
-221,500
-94% -$792K ﹤0.01% 11817
2025
Q3
$1.13M Buy
236,300
+218,200
+1,206% +$1.39M ﹤0.01% 7042
2025
Q2
$165K Sell
18,100
-38,800
-68% -$286K ﹤0.01% 11402
2025
Q1
$514K Buy
+56,900
New +$601K ﹤0.01% 8848
2024
Q4
Sell
-35,200
Closed -$552K 12920
2024
Q3
$552K Buy
35,200
+600
+2% +$9.09K ﹤0.01% 8221
2024
Q2
$467K Sell
34,600
-336,100
-91% -$6.88M ﹤0.01% 8430
2024
Q1
$10.3M Buy
370,700
+308,300
+494% +$6.85M ﹤0.01% 2563
2023
Q4
$1.2M Buy
62,400
+6,000
+11% +$109K ﹤0.01% 6533
2023
Q3
$911K Buy
56,400
+14,900
+36% +$264K ﹤0.01% 6835
2023
Q2
$790K Buy
41,500
+17,400
+72% +$310K ﹤0.01% 7227
2023
Q1
$351K Sell
24,100
-12,100
-33% -$217K ﹤0.01% 9373
2022
Q4
$707K Sell
36,200
-6,800
-16% -$133K ﹤0.01% 6997
2022
Q3
$1.04M Sell
43,000
-5,300
-11% -$163K ﹤0.01% 6553
2022
Q2
$1.52M Sell
48,300
-20,500
-30% -$743K ﹤0.01% 5495
2022
Q1
$3.03M Sell
68,800
-59,700
-46% -$2.56M ﹤0.01% 4597
2021
Q4
$5.59M Buy
128,500
+18,600
+17% +$729K ﹤0.01% 3553
2021
Q3
$3.44M Sell
109,900
-1,700
-2% -$66.9K ﹤0.01% 4667
2021
Q2
$4.72M Sell
111,600
-141,900
-56% -$5.52M ﹤0.01% 4131
2021
Q1
$9.53M Buy
253,500
+82,000
+48% +$2.56M ﹤0.01% 2848
2020
Q4
$4.64M Sell
171,500
-459,100
-73% -$11.8M ﹤0.01% 3528
2020
Q3
$15.8M Buy
630,600
+484,900
+333% +$7.07M ﹤0.01% 1714
2020
Q2
$1.11M Buy
145,700
+27,100
+23% +$198K ﹤0.01% 5674
2020
Q1
$1.08M Sell
118,600
-114,200
-49% -$689K ﹤0.01% 5216
2019
Q4
$1.2M Buy
232,800
+69,000
+42% +$443K ﹤0.01% 5169
2019
Q3
$952K Buy
163,800
+152,900
+1,403% +$686K ﹤0.01% 5795
2019
Q2
$35K Sell
10,900
-34,900
-76% -$119K ﹤0.01% 9913
2019
Q1
$188K Buy
45,800
+25,300
+123% +$160K ﹤0.01% 7914
2018
Q4
$130K Sell
20,500
-30,700
-60% -$319K ﹤0.01% 8076
2018
Q3
$846K Sell
51,200
-1,200
-2% -$20.4K ﹤0.01% 5555
2018
Q2
$876K Buy
52,400
+4,200
+9% +$68K ﹤0.01% 5640
2018
Q1
$750K Buy
48,200
+11,300
+31% +$201K ﹤0.01% 5812
2017
Q4
$697K Buy
36,900
+25,600
+227% +$568K ﹤0.01% 5958
2017
Q3
$330K Buy
11,300
+1,600
+16% +$47.3K ﹤0.01% 7234
2017
Q2
$312K Sell
9,700
-3,400
-26% -$112K ﹤0.01% 7528
2017
Q1
$453K Buy
13,100
+5,900
+82% +$211K ﹤0.01% 6668
2016
Q4
$254K Sell
7,200
-21,700
-75% -$733K ﹤0.01% 8249
2016
Q3
$1M Buy
28,900
+200
+0.7% +$7K ﹤0.01% 4797
2016
Q2
$1.07M Sell
28,700
-3,300
-10% -$124K ﹤0.01% 4744
2016
Q1
$1.29M Sell
32,000
-72,200
-69% -$2.69M ﹤0.01% 4569
2015
Q4
$3.75M Buy
+104,200
New +$3.77M ﹤0.01% 2933

Other funds holding ACH

Susquehanna International Group's ACH Position: Q1 2026 in Review

Susquehanna International Group increased its Accendra Health (ACH) stake by 902% in Q1 2026, buying an estimated $747K and bringing the position to 360,210 shares worth $821K. The position accounts for ﹤0.01% of the portfolio, ranked #8411.

Susquehanna International Group first reported a position in ACH in Q3 2013 and has held it in 45 quarters since. The position peaked at $5.53M in Q4 2016. 142 funds tracked by Wall St. Rank hold ACH as of Q1 2026.

  • Susquehanna International Group held 360,210 shares of Accendra Health worth $821K as of Q1 2026.
  • Susquehanna International Group bought 324,270 Accendra Health shares in Q1 2026, an estimated $747K.
  • Accendra Health made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #8411 holding.
  • Susquehanna International Group first reported a position in Accendra Health in Q3 2013 and has held it in 45 quarters since.
  • Susquehanna International Group's Accendra Health position peaked at $5.53M in Q4 2016.
  • 142 funds tracked by Wall St. Rank held Accendra Health as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.